LDL‐cholesterol versus HDL‐cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos
- 30 April 2012
- journal article
- conference paper
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1254 (1) , 18-32
- https://doi.org/10.1111/j.1749-6632.2012.06480.x
Abstract
Atherosclerosis is a complex disease in which many processes contribute to lesion development. Yet, it is well accepted that high serum levels of low-density lipoproteins (LDL) play a main role in the initiation and progression of atherosclerosis. Despite currently available optimal LDL-lowering therapies, a worrisome number of clinical events still occur. The protective effect of high-density lipoproteins (HDL) in atherosclerosis, either by suppressing vascular LDL accumulation, inflammation, oxidation, endothelial damage, and thrombosis, has supported the need of the use of HDL-raising therapies to address this residual risk. Results obtained in some studies, however, have shown that HDL quality, rather than quantity, should be the target of future pharmacological therapies. Here, we will first explore the mechanism by which excess LDL is fundamental in the development of atherosclerosis and its thrombotic complications, behaving as a factor that introduces chaos in the vascular wall. Afterwards, we will explore how functional HDL, through various cellular and molecular mechanisms, facilitates the resolution of this vascular chaos by suppression of atherosclerosis progression and induction of regression.Keywords
This publication has 103 references indexed in Scilit:
- Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseNew England Journal of Medicine, 2011
- Low high-density lipoprotein cholesterol: current status and future strategies for managementVascular Health and Risk Management, 2010
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJAMA, 2007
- Platelet Activation by Low Density Lipoprotein and High Density LipoproteinPathophysiology of Haemostasis and Thrombosis, 2006
- Implications of emerging risk factors for therapeutic interventionNutrition, Metabolism and Cardiovascular Diseases, 2005
- Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox‐2 expression by VSMCEuropean Journal of Clinical Investigation, 2003
- Oxysterol-activated LXRα/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytesBiochemical and Biophysical Research Communications, 2002
- Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated LysosphingolipidsJournal of Biological Chemistry, 2001
- Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.Circulation, 1979